+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis

American Journal of Gastroenterology 94(7): 1751-1759

OBJECTIVE: The aim of this study was to determine the influence of nitroimidazole resistance (NIR) on the efficacy of treatment for Helicobacter pylori (H. pylori) infections by meta-analysis of the world literature. METHODS: A MEDLINE search, a manual search of all major gastroenterological journals from 1993 to 1997, and abstracts of gastroenterological and H. pylori meetings from 1993 to 1997 were performed. All treatment studies using a nitroimidazole and providing data about the medication used, dose frequency, total daily dose, duration of treatment, and eradication results in relation to NIR were included. Eradication had to be assessed by two biopsy-based tests or a urea breath test gtoreq4 wk after treatment. Individual studies were pooled into groups according to the medication used and the duration of treatment. The pooled estimate of the odds ratio (OR) of NIR for treatment failure and its 95% confidence interval (95% CI) were calculated for each group using the logit method. To detect any possible bias, funnel plots (plots of effect estimates against sample size) were constructed. RESULTS: A total of 91 treatment arms, including a total of 4823 patients, were evaluated. The pooled ORs of NIR for treatment failure (95% CI) of protonpump inhibitors, bismuth, and quadruple regimens were 5.2 (3.8-7.1), 5.9 (4.1-8.3), and 7.0 (3.1-16.0), respectively. Eradication rates were 90% in susceptible strains but <75% in resistant strains. In susceptible strains, neither treatment duration nor the choice of the second antibiotic influenced efficacy. In resistant strains, tetracycline was more effective than amoxicillin (bismuth regimens), and the longer the duration of regimens (bismuth-amoxicillin regimens) the more effective they were. Only quadruple regimens given for gtoreq1 wk were effective in resistant strains. CONCLUSIONS: NIR decreases treatment efficacy. Treatment duration and choice of other drugs influence the impact of NIR on treatment efficacy. If NIR is present, a nitroimidazole-containing regimen should be avoided or a quadruple regimen should be given for >1 wk.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 011518055

Download citation: RISBibTeXText

PMID: 10406231

DOI: 10.1111/j.1572-0241.1999.01202.x

Related references

Proton pump inhibitor, clarithromycin and amoxicillin or nitroimidazole A meta-analysis of its efficacy on Helicobacter pylori eradication. Gut 47(Suppl. 1): A104, 2000

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: A meta-analysis of eradication of Helicobacter pylori. Alimentary Pharmacology & Therapeutics 14(10): 1319-1328, 2000

Proton pump inhibitors , clarithromycin and amoxicillin or a nitroimidazole for one week A meta-analysis of its efficacy on H pylori eradication. Gastroenterology 118(4 Suppl 2 Part 1): AGA A496, 2000

Review article: Nitroimidazole resistance in Helicobacter pylori. Alimentary Pharmacology & Therapeutics 14(1): 7-14, 2000

Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation. Journal of Physiology and Pharmacology 48(Suppl. 4): 25-38, 1997

Surveillance of Helicobacter pylori resistance to macrolides and nitroimidazole compounds at a nation level. American Journal of Gastroenterology 89(8): 1368, 1994

5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents. Archiv der Pharmazie 344(3): 178-183, 2011

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35(11): 1562-1566, 1994

Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. Journal of Antimicrobial ChemoTherapy 66(8): 1756-1765, 2011

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. Journal of Clinical Pathology 41(2): 207-210, 1988

Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Molecular Microbiology 72(2): 518-536, 2009

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: Impact of two second-line therapies in a randomized study. Alimentary Pharmacology & Therapeutics 16(2): 315-324, 2002

Meta-analysis of determining the pathogen eradicating efficacy of various therapeutic regimens in Helicobacter pylori infection. Wiener Medizinische Wochenschrift 148(20): 464-468, 1998

Efficacy of 5-nitroimidazole compounds for giardiasis in Cuban children: systematic review and meta-analysis. Le Infezioni in Medicina 27(1): 58-67, 2019

The efficacy of first-line regimens for Helicobacter pylori eradication in different continents: A systematic review and network meta-analysis protocol. Medicine 97(50): E13682, 2018